Actively Recruiting
A Pilot Study To Assess The Dynamic Difficulty Adjustment In Personalized Testing For Persons With MCI And Matched Healthy Controls
Led by Indivi AG · Updated on 2025-09-16
55
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the usability and functionality of the Indivi mobile application for cognitive activities in people with mild cognitive impairment or mild Alzheimer's disease and in healthy individuals aged 50 to 90. This observational study aims to determine if the app's dynamic difficulty adjustment (DDA) system reaches a stable difficulty level at the same rate and level for both groups, and if it can effectively distinguish between them based on cognitive activity results. Participants will use the Indivi mobile application with its built-in DDA system over a 6-week period. The app customizes the difficulty of cognitive activities to each user, adapting as they progress. The study compares results from two groups: those with mild cognitive impairment or mild Alzheimer's disease and healthy controls. During the study, participants will complete cognitive activities using the mobile app while researchers monitor the number of test iterations until a stable difficulty level is reached and the distribution of participants across assessment levels at that steady state. The study involves regular app use over the 6 weeks, with no additional treatments or interventions. Outcomes focus on the app's performance and ability to monitor cognitive function.
CONDITIONS
Brief Title
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is part of BU-ADRC cohort
- Diagnosed with mild cognitive impairment, mild Alzheimer's disease, or classified as healthy control per BU-ADRC
- Inclusion data obtained less than 2 years before enrollment
- Age between 50 and 90 years
- Able to use a smartphone
- Sufficient knowledge of English
- Able and intends to follow study procedures
- Provided informed consent with signature
You will not qualify if you...
- Any neurological condition contributing to cognitive impairment beyond MCI or AD
- Psychiatric diagnosis or symptoms (e.g., hallucinations, major depression, delusions) interfering with study
- History of stroke or seizures within the last 24 months
- Geriatric Depression Scale score of 8 or higher
- Severe visual or hearing impairment affecting cognitive assessments
- Known or suspected non-compliance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 weeks
Participants use the Indivi Mobile Application to monitor cognitive performance over time.
Regular app-based assessments during the study period
Trial Site Locations
Total: 1 location
1
Boston University School of Medicine
Boston, Massachusetts, United States, 02118
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here